Literature DB >> 25754452

What Role Does Mycobacterium avium subsp. paratuberculosis Play in Crohn's Disease?

Horacio Bach1.   

Abstract

Crohn's disease (CD) is a chronic, debilitating inflammatory bowel disease with no etiological agent yet identified. Studies have demonstrated that the bacterium Mycobacterium avium subsp. paratuberculosis (MAP) is present in a high percentage of CD patients. Although MAP has been isolated from human specimens, current techniques fail to show the presence of MAP in 100 % of tissues or biopsies obtained from CD patient lesions, and thus MAP cannot meet Koch's postulate as the etiological agent of CD. In this report, the effect of genetic and immune factors as well as the presence of MAP as a potential environmental factor is analyzed.

Entities:  

Year:  2015        PMID： 25754452     DOI： 10.1007/s11908-015-0463-z

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


  97 in total

1.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

Review 2.  Immunology of mycobacterial infections: with special reference to Mycobacterium avium subspecies paratuberculosis.

Authors:  Jagdeep Singh Sohal; S V Singh; P Tyagi; Swati Subhodh; P K Singh; A V Singh; K Narayanasamy; Neelam Sheoran; Komal Singh Sandhu
Journal:  Immunobiology       Date:  2008-03-04       Impact factor: 3.144

3.  Fibronectin attachment protein homologue mediates fibronectin binding by Mycobacterium avium subsp. paratuberculosis.

Authors:  T E Secott; T L Lin; C C Wu
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Incidence of Mycobacterium paratuberculosis in bulk raw and commercially pasteurized cows' milk from approved dairy processing establishments in the United Kingdom.

Authors:  Irene R Grant; Hywel J Ball; Michael T Rowe
Journal:  Appl Environ Microbiol       Date:  2002-05       Impact factor: 4.792

Review 5.  Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis.

Authors:  Martin Feller; Karin Huwiler; Roger Stephan; Ekkehardt Altpeter; Aijing Shang; Hansjakob Furrer; Gaby E Pfyffer; Thomas Jemmi; Andreas Baumgartner; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2007-09       Impact factor: 25.071

6.  Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro.

Authors:  Sung Jae Shin; Michael T Collins
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

7.  Study of animal-borne infections in the mucosas of patients with inflammatory bowel disease and population-based controls.

Authors:  Charles N Bernstein; Gopi Nayar; Andre Hamel; James F Blanchard
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 8.  T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade.

Authors:  Dmitry V Ostanin; Jianxiong Bao; Iurii Koboziev; Laura Gray; Sherry A Robinson-Jackson; Melissa Kosloski-Davidson; V Hugh Price; Matthew B Grisham
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

9.  Survival and dormancy of Mycobacterium avium subsp. paratuberculosis in the environment.

Authors:  Richard J Whittington; D Jeff Marshall; Paul J Nicholls; Ian B Marsh; Leslie A Reddacliff
Journal:  Appl Environ Microbiol       Date:  2004-05       Impact factor: 4.792

10.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157
View more
  7 in total

1.  Global Phylogeny of Mycobacterium avium and Identification of Mutation Hotspots During Niche Adaptation.

Authors:  Rachel Mizzi; Karren M Plain; Richard Whittington; Verlaine J Timms
Journal:  Front Microbiol       Date:  2022-05-06       Impact factor: 6.064

Review 2.  Advances in nutritional therapy in inflammatory bowel diseases: Review.

Authors:  Andrzej Wędrychowicz; Andrzej Zając; Przemysław Tomasik
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

3.  Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis.

Authors:  V Gupta; R Rodrigues; D Nguyen; J Sauk; H Khalili; V Yajnik; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2015-11-05       Impact factor: 8.171

4.  Vaccination sequence effects on immunological response and tissue bacterial burden in paratuberculosis infection in a rabbit model.

Authors:  Rakel Arrazuria; Elena Molina; Joseba M Garrido; Valentín Pérez; Ramón A Juste; Natalia Elguezabal
Journal:  Vet Res       Date:  2016-08-05       Impact factor: 3.683

5.  Combinatorial Discriminant Analysis Applied to RNAseq Data Reveals a Set of 10 Transcripts as Signatures of Exposure of Cattle to Mycobacterium avium subsp. paratuberculosis.

Authors:  Michela Malvisi; Nico Curti; Daniel Remondini; Maria Grazia De Iorio; Fiorentina Palazzo; Gustavo Gandini; Silvia Vitali; Michele Polli; John L Williams; Giulietta Minozzi
Journal:  Animals (Basel)       Date:  2020-02-05       Impact factor: 2.752

6.  Crohn's strictures open with anti-mycobacterial antibiotic therapy: A retrospective review.

Authors:  Rhys Collyer; Annabel Clancy; Gaurav Agrawal; Thomas J Borody
Journal:  World J Gastrointest Endosc       Date:  2020-12-16

Review 7.  Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets.

Authors:  Teodora-Ecaterina M Manuc; Mircea M Manuc; Mircea M Diculescu
Journal:  Clin Exp Gastroenterol       Date:  2016-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.